期刊文献+

急性心肌梗死患者血清尿酸水平与非高密度脂蛋白胆固醇和血浆致动脉硬化指数相关性研究 被引量:3

下载PDF
导出
摘要 目的:探讨急性心肌梗死(AMI)患者血清尿酸(UA)水平与非高密度脂蛋白胆固醇(HDL-C)、血浆致动脉硬化指数(AIP)水平相关性及临床意义。方法:分别测定89例男性AMI患者UA、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、HDL-C,计算出非HDL-C、AIP;按UA水平分成高尿酸组(37例)及尿酸正常组(52例)。比较2组TG、TC、LDL-C、HDL-C、非HDL-C及AIP水平,并分析UA与非HDL-C、AIP相关性。结果:与尿酸正常组比,高尿酸组TG、TC、非HDL-C、AIP水平明显升高(P<0.05),而LDL-C、HDL-C水平差异比无统计学意义;相关分析显示,UA与TG、TC、非HDL-C、AIP正相关(P<0.05),与HDL-C负相关(P<0.05)。结论:联合检测AMI合并高尿酸血症患者血浆AIP、非HDL-C水平比其他血脂指标能更好预测心血管事件。
出处 《汕头大学医学院学报》 2015年第3期155-156,162,共3页 Journal of Shantou University Medical College
  • 相关文献

参考文献7

  • 1ZHU Y, PANDYA B J, CHOI H K. Comorbidities of goutand hyperuricemia in the US general population: NHANES2007-2008 [J]. Am J Med, 2012, 125(7): 679-687.
  • 2SOANS G, MURGOD R. Evaluation of role of hype-ruricemia as an active component of metabolic syndrome [J].Int J Analyt Pharm Biomed Sci, 2012,1 (1) : 65-72.
  • 3美国国家脂质协会.2014NLA成人血脂异常集中管理建议.NLA官网.
  • 4秦勤,耿婕,崔让庄,毛用敏,寇璐,赵炳让,惠汝太.冠心病患者血浆纤维蛋白原与小而密低密度脂蛋白的关系[J].中华心血管病杂志,2003,31(8):584-587. 被引量:21
  • 5KITAMURAA, NODAH, NAKAMURAM, etal. Associ-ation between non-high-density lipoprotein cholesterol levelsand the incidence of coronary heart disease among Japanese:the Circulatory Risk in Communities Study (CIRCS) [J]. JAtheroscer Thromb,2011? 18 (6) : 454-463 .
  • 6BOEKHOLDT S M, ARSENAULT B J,MORA S,eta 1. Association of LDL cholesterol,non-HDL cholesterol,and apolipoprotein B levels with risk of cardiovascularevents among patients treated with statins: a meta-analysis[J]. JAMA, 2012,307(12): 1302-1309.
  • 72014年中国胆固醇教育计划血脂异常防治专家建议[J].中华心血管病杂志,2014,42(8):633-636. 被引量:154

二级参考文献15

  • 1中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南.中华心血管病杂志,2001,29:315-317.
  • 2Miller BD, Alderman EL, Haskdl WL, et al. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation, 1996, 94: 2146-2153.
  • 3Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem, 1988, 2: 78-83.
  • 4Krauss RM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr, 2001,21.283-295.
  • 5Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet, 1986, 2:592-595.
  • 6Kevin CM, Michael HD, Phyllis M, et al. Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. Am J Cardiol, 2000, 85: 451-456.
  • 7Martin H, Aloys B, Joseph K, et al. Association between serum fibrinogen concentration and HDL and LDL subfraction phenotypes in healthy men. Arterioscler Thromb Vasc Biol, 1996, 16: 144-148.
  • 8Stone NJ,Robinson J,Lichtenstein AH,et al.2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J].Circulation,2013,pii:S0735-1097 (13)06028-2.
  • 9Scandinavian simvastatin survival study group.Randomised trial of lowering in 4444 patients with coronary heart disease:the Scandinavian simvastatin survival study (4S)[J].Lancet,1994,344:1383-1389.
  • 10Sharp collaborative group.Study of heart and renal protection (SHARP):randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9438 patients with chronic kidney disease[J].Am Heart J,2010,160:785-794.e10.

共引文献173

同被引文献18

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部